NATICK, Mass., May 27, 2025 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced they have finalized $34.5M in funding, including a strategic investment from Illumina, structured financing from Soleus Capital and investments from existing investors.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.